Browse All

Current Filters

CLEAR FILTER x

TITLE

Title
    Author Last Name
      Session Name
        Topic
          Program Number
            Author Institution

              A Phase 1, First-in-human, Randomized, Double-blind, Placebo-controlled, Single and Multiple Ascending Intravenous Dose Study of a novel TREM2 agonist (VGL101) in Healthy Volunteers (HVs)

              Author:Papapetropoulos, Spyridon   Meier, Andreas   O'Mara, Ryan   Marsh, Andrew   Neelon, Kelly   Rajagovindan, Rajasimhan   Thackaberry, Evan   Stiles, David   

              Session Name:S14: General Neurology: Emerging Therapies  

              Topic:General Neurology  

              Program Number:S14.004  

              Author Institution:Vigil Neuroscience, Cambridge, MA  Consultant, Cambridge, MA